HIV CURE SYMPOSIUM 2022
Welcome
The HIV Cure Research Center Ghent is very pleased to invite you to the 8th HIV Cure Symposium that will be held in the beautiful city of Ghent, Flanders, Belgium on September 12-13, 2022.
The HIV Cure Symposium will comprehensively summarize the state of the art in HIV cure strategies and diagnostic tools to monitor therapeutic interventions.
Distinguished speakers such as Marcus Buggert, Mathias Lichterfeld, Ya-Chi-Ho, Nicolas Chomont, Javier Martinez-Picado, John Frater, Rafick Sékaly, Ole Søgaard, Sarah Fidler, Marion Pardons, Tine Struyve, Evy Blomme, Casper Rokx and Jozefien De Clercq will highlight the latest developments and progress in HIV Cure research. We will discuss key topics: single cell approaches, the HIV reservoir, acute seroconversion and HIV cure strategies.
Program
Time Zone: Central European Summer Time (CEST)
| Monday, September 12, 2022 | |
|---|---|
| 12.30-13.00 | Registration |
| 13.00-13.10 | Welcome and Introduction |
| 13.10-15.00 | SINGLE CELL APPROACHES TO IDENTIFY HIV RESERVOIRS Chaired by Zeger Debyser and Sarah Gerlo |
| 13.10-13.40 | How memory T cells recognize and eliminates viral infections Marcus Buggert, Karolinska Institute, Solna, Sweden |
| 13.40-14.10 | Novel single-cell assays for profiling HIV-1 reservoir cells Mathias Lichterfeld, Brigham and Women’s Hospital and Ragon Institute of MGH, MIT and Harvard, Boston, United States |
| 14.10-14.40 | Single-cell multi-omics understanding of HIV-induced immune dysfunction Ya-Chi Ho, Yale University, New Haven, United States |
| 14.40-15.00 | 2 selected abstracts: 2x10 min bullet presentation |
| 15.00-15.20 | Break |
| 15.20-16.40 | THE TRANSLATIONAL COMPETENT RESERVOIR Chaired by Mathias Lichterfeld and Ya-Chi-Ho |
| 15.20-15.50 | The phenotype of T cells with intact HIV genomes Nicolas Chomont, Université de Montréal, Montréal, Canada |
| 15.50-16.20 | Potent latency reversal enables in-depth transcriptomic analyses of the translation-competent HIV reservoir Marion Pardons, HIV Cure Research Center, Ghent University, Belgium |
| 16.20-16.40 | 2 selected abstracts: 2x10 min bullet presentation |
| 16.40-17.00 | Break |
| 17.00-17.30 | SATELLITE VIIV HEALTHCARE |
| 17.00-17.30 | Prospects for an HIV Cure – The ViiV Perspective Jan van Lunzen, Global Medical Director of ViiV Healthcare, London, United Kingdom |
| 17.30-18.15 | COLLABORATIVE CURE EFFORTS |
| 17.30-17.45 | Concerted action towards an HIV cure in Europe: EU2CURE Casper Rokx, Erasmus MC, Rotterdam, the Netherlands |
| 17.45-18.00 | 2000HIV study: multi-omics analysis in 2000 PLHIV using long-term cART Andre van der Ven, Radboudumc, Nijmegen, the Netherlands |
| 18.00-18.15 | Reversing Immune Dysfunction for HIV-1 eradication (RID-HIV) Rafick-Pierre Sekaly, Emory University, Atlanta, United States |
| 18.15-19.30 | NETWORK RECEPTION |
| Tuesday, September 13, 2022 | |
|---|---|
| 08.30-09.00 | Registration |
| 09.00-10.20 | HOW TO QUANTIFY THE VIRAL RESERVOIR IN HIV CURE STUDIES Chaired by Ole Søgaard and John Frater |
| 09.00-09.30 | The multitask efforts of measuring viral persistence Javier Martinez-Picado, ICREA Research Professor at IrsiCaixa Research Institute, Associate Professor at the University of Vic , Barcelona, Spain |
| 09.30-10.00 | Setting up a high throughput pipeline to measure the intact proviruses Evy Blomme, HIV Cure Research Center, Ghent University, Belgium |
| 10.00-10.20 | 2 selected abstracts: 2x10 min bullet presentation |
| 10.20-10.40 | Break |
| 10.40-12.00 | ACUTE HIV INFECTION: LESSONS LEARNED SO FAR Chaired by Nicolas Chomont and Carine Van Lint |
| 10.40-11.10 | The profiling of the HIV reservoir in patients treated during acute seroconversion Tine Struyve, HIV Cure Research Center, Ghent University, Belgium |
| 11.10-11.40 | In-situ characterization of HIV reservoir microenvironments and inflammatory milieu in lymphoid tissues of patients treated during acute HIV infection Jozefien De Clercq, HIV Cure Research Center, Ghent University, Belgium |
| 11.40-12.00 | 2 selected abstracts: 2x10 min bullet presentation |
| 12.00-13.30 | Lunch |
| 13.30-13.50 | PATIENTS PERSPECTIVES |
| 13.30-13.50 | Patient perspectives on HIV Cure in Europe Giulio Maria Corbelli, European AIDS Treatment Group (EATG) |
| 13.50-16.40 | REACHING AN HIV CURE Chaired by Linos Vandekerckhove and Javier Martinez-Picado |
| 13.50-14.20 | T-cell immunity in the context of bNAbs and the search for a vaccinal effect John Frater, University of Oxford, England, United Kingdom |
| 14.20-14.50 | Convergent immune based approaches to the Control of viral rebound post ATI Rafick-Pierre Sekaly, Emory University, Atlanta, United States |
| 14.50-15.20 | Break + poster session |
| 15.20-15.50 | Results from eCLEAR study Ole Søgaard, Aarhus University Hospital, Aarhus, Denmark |
| 15.50-16.20 | Current ongoing bNAbs studies in the UK Sarah Fidler, Imperial College London, London, United Kingdom |
| 16.20-16.40 | 2 selected abstracts: 2x10 min bullet presentation |
| 16.40-16.50 | CLOSING REMARKS |
Registration
Call for abstracts
The HIV Cure Research Center invites you to submit abstracts for oral presentations for the HIV Cure Symposium to be held on 12-13 September 2022 in Ghent. The length of abstracts for presentations should not exceed 350 words. Ten minutes will be foreseen for each selected poster presentation.
The deadline for abstract submission is July 22, 2022. Notification of acceptance will be made on July 30th 2022. Please send abstracts as a Pdf document to Linos Vandekerckhove, linos.vandekerckhove@ugent.be by July 30th.
Venue
The HIV Cure Symposium will take place in Auditorium Oehoe, Building E1, Coupure Links, Gent, Belgium
How to get there:
From Sint-Pietersstation – Auditoriom Oehoe: 2.3 km
From the station you can take tram 2 or 4 at platform 20, stop Rozemarijnbrug, 5 min walk to Auditorium Oehoe.
Organizing Committee
Prof. Dr. Linos Vandekerckhove – Head of the HIV Cure Research Center – Ghent University Belgium
Prof. Dr. Sarah Gerlo – PI HIV Cure Research Center – Ghent University – Belgium
Prof. Zeger Debyser – Heaed of the Molecular Virology and Gene Therapy Unit – KU Leuven – Belgium
Karen Vervisch – Lab Manager – Ghent University Hospital – Belgium
2021 in preview
Interested in re-watching the 2021 HIV Cure and SARS-CoV-2 Hybrid Symposium that was held in Zellik, Belgium?
Contact
Karen Vervisch
Karen.vervisch@uzgent.be
+32 (0) 9 332 94 25
Sponsors
If your company is interested in sponsoring the HIV Cure Symposium, please contact karen.vervisch@uzgent.be / +32 9 332 9425
WERELDWIJD LEVEN 37 MILJOEN MENSEN MET HIV. STEUN HET FONDS HIV ONTRAFELEN en Help hen.
Door de COVID-19 maatregelen zal de 7de editie pas in december 2022 plaatsvinden.
Doe een online gift
-
Of via overschrijving:
Universiteitsfonds UGent - IBAN BE26 3900 9658 0329
- BIC BBRUBEBB
- Met duidelijke vermelding: HIVOntrafelen
- Giften vanaf 40 euro per jaar zijn 45% fiscaal aftrekbaar. Meer informatie: www.ugent.be/iksteunmee